BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14972566)

  • 21. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
    Kim SK; Shakya AK; O'Callaghan DJ
    J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice.
    Ruitenberg KM; Walker C; Love DN; Wellington JE; Whalley JM
    Vaccine; 2000 Jan; 18(14):1367-73. PubMed ID: 10618534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
    Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
    Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1.
    Fuentealba NA; Zanuzzi CN; Scrochi MR; Sguazza GH; Bravi ME; Cid de la Paz V; Corva SG; Portiansky EL; Gimeno EJ; Barbeito CG; Galosi CM
    J Comp Pathol; 2014 Nov; 151(4):384-93. PubMed ID: 25124330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
    Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
    J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
    von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
    Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of DNA-mediated vaccination for equine herpesvirus 1.
    Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle.
    Loehr BI; Rankin R; Pontarollo R; King T; Willson P; Babiuk LA; van Drunen Littel-van den Hurk S
    Virology; 2001 Oct; 289(2):327-33. PubMed ID: 11689054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1.
    Braun RP; Babiuk LA; Loehr BI; van Drunen Littel-van den Hurk
    Virology; 1999 Dec; 265(1):46-56. PubMed ID: 10603316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ
    Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
    Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
    Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
    Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S; Josefsson A; Holmgren J; Harandi AM
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
    Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.